New fluid could keep transplant organs healthier longer

NCT ID NCT03627013

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This phase 3 trial tests a new solution called Custodiol-N for preserving donated kidneys, livers, and pancreases before transplant. About 362 recipients will be randomly assigned to receive organs stored in either Custodiol-N or the standard Custodiol solution. The goal is to see if Custodiol-N works as well or better at preventing early organ damage and reducing the need for dialysis after kidney transplant.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Custodiol-N solution (organ preservation fluid)
What this could lead to
If it works, this could lead to better preservation of donated organs, reducing the need for dialysis after kidney transplant and improving liver function after transplant.
What could go wrong
This is a non-inferiority trial, meaning it only aims to show Custodiol-N is as good as the current solution, not necessarily better. Results may not apply to all transplant centers or organ types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University Graz

    RECRUITING

    Graz, Austria

  • Medical University Innsbruck

    RECRUITING

    Innsbruck, Austria

  • Medical University Vienna

    RECRUITING

    Vienna, Austria

  • Ordensklinikum Linz

    RECRUITING

    Linz, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.